Logiscreen

Takeda Pharmaceutical Company

$15.60
Market Cap 49.28B
ROE 2.6%
Gross Margin 62.9%
Debt/Equity 0.7
Current Ratio 1.3
Revenue QoQ 3.9%
EPS QoQ -0.8%
F-Score 5

About

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
40.72
vs median 33.61
P/B
1.00
vs median 2.16
ROE
0.03
vs median 0.09

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics